Skip to Main Content

INFORMATION FOR

Gastrointestinal CRT

Objective:

  • To safely conduct a range of phase I, II and III clinical trials across the spectrum of GI Cancers to meet the needs of our diverse catchment area.
Research Team Meetings: Thursday @ 3:30pm - 4:15pm

GI Team Leader

  • Associate Professor of Internal Medicine (Medical Oncology); Director, Center for Gastrointestinal Cancers at Smilow Cancer Hospital and Yale Cancer Center; Chief, GI Medical Oncology; Vice Chief, Diversity, Equity, and Inclusion, Medical Oncology

    Dr. Kunz specializes in the treatment of gastrointestinal malignancies. Her research involves clinical trials and epidemiologic studies, primarily in neuroendocrine and gastroesophageal cancers. She is an international leader in the clinical care of patients with neuroendocrine tumors (NETs) and is advancing the field through clinical trials and translational science that are defining the next generation of therapies for patients with this rare diagnosis. She is the current president of the North American Neuroendocrine Tumor Society (NANETS). Learn more about Dr. Kunz >>

Members